Alliance Resources​

Supply chain disruption report Pfizer Rocky Mount facility

The End Drug Shortage Alliance announced recommended actions healthcare industry stakeholders should immediately take to help minimize supply chain disruptions of sterile injectable medications in the wake of the tornado that hit Pfizer’s Rocky Mount, North Carolina facility.
READ MORE+

Drug Shortage Stewardship: closed Teva location in Irvine, California

Recently Teva closed a manufacturing plant in Irvine, California. This document provides a market analysis of the affected products and is also intended to aid in understanding the current supply chain​
READ MORE+

White paper: Implications of the National BCG Drug Shortage

Since 2019, Bacillus Calmette-Guerin (BCG), used in the treatment of bladder cancer, has experienced a significant supply disruption due to a reduction in the number of pharmaceutical manufacturers in the market.
​READ MORE+​

Supply chain disruption due to manufacturer closure

Akorn Pharmaceuticals has shut down all US operations secondary to bankruptcy. Prior to Akorn closing, their portfolio included over 100 medications. The generic manufacturer most noted for their ophthalmic products was also the sole manufacturer for numerous acute care injectables.​
READ MORE+

Drugmakers urged to boost production of bladder cancer drug (fiercepharma.com)

Amid a global drug shortage, thousands of patients with bladder cancer are unable to receive their recommended treatment each year. While Merck has pledged to make as many doses as it can, the company’s efforts aren't enough.
​READ MORE+

Thousands of people can't get full treatments of a lifesaving cancer drug (CNN)

"This is a terrible crisis. We should be doing everything we can to give every single one of these patients the best chance of survival," said Laura Bray, a board member of the End Drug Shortages Alliance, one of the sponsors of the report. "It's heartbreaking, and we must do better."
READ MORE+